(DHQD)2PHAL: A Premier Chiral Catalyst for Precision Synthesis
(DHQD)2PHAL: Driving innovation in asymmetric synthesis and pharmaceutical intermediate production.
Get a Quote & SampleProduct Core Value

(DHQD)2PHAL
This dimeric cinchona alkaloid derivative is a cornerstone in enantioselective catalysis, widely recognized for its efficacy in Sharpless Asymmetric Dihydroxylation and various asymmetric halofunctionalization reactions. Its precise stereochemical control makes it invaluable for the synthesis of chiral vicinal diols, which are crucial building blocks in the total synthesis of complex natural products and advanced pharmaceutical intermediates. The unique structure of (DHQD)2PHAL enables the creation of specific enantiomers, a critical requirement for developing novel therapeutic agents and fine chemicals.
- Unlock precise stereochemical control using (DHQD)2PHAL in Sharpless asymmetric dihydroxylation.
- Leverage (DHQD)2PHAL for high-yield asymmetric halofunctionalization reactions, creating valuable chiral heterocycles.
- Accelerate your pharmaceutical intermediate synthesis with the catalytic power of (DHQD)2PHAL.
- Explore the synthesis of natural products through advanced asymmetric catalysis facilitated by (DHQD)2PHAL.
Key Advantages
Exceptional Enantioselectivity
Achieve high enantiomeric excesses in reactions like asymmetric dihydroxylation, crucial for pharmaceutical intermediate synthesis.
Broad Substrate Scope
Effectively catalyze a wide array of reactions, from alkene dihydroxylation to halolactonization, supporting diverse research needs.
Catalytic Efficiency
Enables efficient synthesis with low catalyst loadings, reducing costs and environmental impact in your synthetic processes.
Key Applications
Natural Product Synthesis
Used as a key chiral catalyst for creating stereochemically defined intermediates in the synthesis of complex natural products.
Pharmaceutical Intermediates
Essential for producing enantiomerically pure intermediates required for drug discovery and development, facilitating efficient pharmaceutical intermediate synthesis.
Asymmetric Halofunctionalization
Catalyzes critical reactions like chlorolactonization and bromoesterification, yielding valuable chiral heterocyclic compounds.
Advanced Organic Synthesis
Enables sophisticated transformations, including Sharpless Asymmetric Dihydroxylation, for building complex molecular architectures.